‘Deeply concerns me’: Original prescriber’s alarm over cannabis trends Medicinal cannabis prescription rates are skyrocketing, with sales in the first half of 2024 almost equal to all of 2023 – but it comes amid mounting concern.
In Practice: EOIs for 2025 Hackathon event The RACGP’s Hackathon provides the opportunity to be part of developing solutions to general practice challenges, and GPs can apply now.
In Practice: Member forum on governance The RACGP is inviting members attending GP24 to join a governance discussion to help shape the future of the college.
Australian-first STI self-test receives TGA approval The test for chlamydia and gonorrhoea could result in timelier diagnosis, but are there implications of doing so outside the healthcare setting?
IV fluid supplies still a concern for rural GPs As wellness industry demand for IV fluids comes under increasing scrutiny, stocks remain a worry for GPs in more remote areas.
Medical devices impacted by 3G shutdown GPs are being urged to speak to their patients and take ‘necessary precautions’ as essential devices and alarms could be affected.
TGA rejects Alzheimer’s medication due to safety concerns Advocates say the decision not to register lecanemab is a missed opportunity to begin reversing impacts of Alzheimer’s disease.
TGA urges ‘extreme caution’ amid fake Ozempic pen imports GPs are being warned to lookout for the counterfeit pens and are urged to inform their patients, with one person already suffering life-threatening complications.
‘Visionary’ review suggests quicker approval of new medicines New subsidised medication approvals would be streamlined and access made easier for vulnerable populations, under a new health technology plan.
Concern for rural practices as IV fluid shortage bites The TGA is working to find suitable alternatives, with the unprecedented shortage expected to last at least until the end of the year.